Effects of Magnetic Fluid Hyperthermia (MFH) on C3H mammary carcinoma in vivo

International Journal of Hyperthermia

Volumn 13, Issue 6, 1997, Pages 587-605

  Jordan, A ^a   Scholz, R ^a   Wust, P ^a   Fahling H ^a   Krause, J ^a   Wlodarczyk, W ^a   Sander, B ^a   Vogl, Th ^a   Felix, R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cancer therapy; Inductive heating; Interstitial; Magnetic fluid hyperthermia; Magnetic fluids

Indexed keywords

DEXTRAN MAGNETITE;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; HYPERTHERMIC THERAPY; INTRATUMORAL DRUG ADMINISTRATION; MAGNETIC FIELD; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REGRESSION ANALYSIS; TEMPERATURE; TIME; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VOLUME;

EID: 0030722914     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.3109/02656739709023559     Document Type: Article

References (40)

1. BACON, B. R., STARK, D. D., PARK, C. H., SAINI, S., GROMAN, E. V., HAHN, P. F., COMPTON, C. C. and FERRUCCI, J. T., 1987. Ferrite particles: A new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatoxicity after intravenous administration. The Journal of Laboratory and Clinical Medicine, 110, 164-171.
2. BARRY, J. W., BOOKSTEIN, J. J. and ALKSNE, J. F., 1981. Ferromagnetic embolization. Experimental evaluation. Radiology, 138, 341-349.
3. BULTE, J. W. M., DE JONGE, M. W. A., KAMMAN, R. L., Go, K. G., ZUIDERVEEN, F., BLAAUW, B., OOSTERBAAN, J. A., THE, T. H, and DE LEIJ, L., 1992. Dextran-magnetite particles: contrast-enhanced MRI of blood-brain barrier disruption in a rat model. Magnetic Resonance in Medicine, 23, 215-223.
4. CHAN, D. C. F., KIRPOTIN, D. B. and BUNN, P. A., 1993. Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer. Journal of Magnetism and Magnetic Materials, 122, 374-378.
5. CHOU, C.-K., 1990. Use of heating rate and specific absorption rate in the hyperthermia clinic. International Journal of Hyperthermia, 6, 367-370.
6. COHEN, D., 1973. Ferromagnetic contamination in the lungs and other organs of the human body. Science, 180, 745-748.
7. GORDON, R. T., HINES, J. R. and GORDON, D., 1979. Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. Medial Hypothesis, 5, 83-102.
8. GORDON, R. T., 1988a. Treating cancer cells in vivo - by alteration electric and magnetic dipoles intracellularly by introduction of minute particles. US patent No. 4767611.
9. GORDON, R. T., 1988b. Diagnostic and therapeutic comparisons - containing metal transferrin dextran particles have high target cell selectively especially for treating cancer by inductive heating. US Patent No. 4735796.
10. GORDON, R. T., 1987a. Use of magnetic susceptibility probes in the treatment of cancer. US Patent No. 4662359.
11. GORDON, R. T., 1987b. Selective treatment of cancer cells - using minute particles which can be inductively heated as magnetic susceptibility probes. US Patent No. 4662359.
12. GORDON, R. T., 1980. Cancer-treating composition containing inductively - heatable particles. UK Patent Application 2024007.
13. HAHN, P. F., STARK, D. D., SAINI, S., LEWIS, J. M., WITTENBERG, J. and FERRUCCI, J. T., 1987. Ferrite particles for bowel contrast in MR imaging: design issues and feasibility studies. Radiology, 164, 37-41.
14. HAMM, B., VOGL, T. J. and BRANDING, G., 1992. Focal liver lesions: MR imaging with MN-DODP: initial clinical results in 40 patients. Radiology, 182, 167-174.
15. HAMM, B., REICHEL, M., VOGL, T., TAUPITZ, M. and WOLF, K. J., 1994. Superparamagnetic iron particles. The clinical results in the MR diagnosis of liver metastases. Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin, 160, 52-58.
16. JORDAN, A., 1993. Magnetfeld-Ferrit-Hyperthermie, Thesis of the Freie Universität Berlin, Fachbereich Biologie (in German).
17. JORDAN, A., WUST, P., FAHLING, H., JOHN, W., HINZ, A. and FELIX, R., 1993. Inductive heating of ferromagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. International Journal of Hyperthermia, 9, 51-68.
18. JORDAN, A., WUST, P., SCHOLZ, R., TESCHE, B., FÄHLING, H., MITROVICS, T., VOGL, T., CERVȮS-NAVARRO, J. and FELIX, R., 1996. Biological effects of biocompatible magnetic fluids in AC magnetic fields. Cytotoxicity, intracellular uptake and inactivation of malignant cells in vitro. International Journal of Hyperthermia, 12, 705-722.
19. JORDAN, A., WUST, P., SCHOLZ, R., FÄEHLING, H., KRAUSE, J., and FELIX, R., 1997, Magnetic fluid hyperthermia (MFH). In Scientific and Clinical Applications of Magnetic Carriers, edited by U. Häfeli, W. Schütt, J. Teller, M. Zborowski (New York, London: Plenum Press), pp. 569-595.
20. KAWAMORI, Y., MATSUI, O., KADOYA, M., YOSHIKAWA, J., DEMACHI, H. and TAKASHIMA, T., 1992. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging. Radiology, 183, 65-72.
21. KIRSCHVINK, J. L., KOBAYASHI-KIRSCHVINK, A. and WOODFORD, B. J., 1992. Magnetite biomineralization in the human brain. Proceedings of the National Academy of Sciences U.S.A., 89, 7683-7687.
22. MAGDON, E. and WINTERFELD, G., 1975. Untersuchungen zum Wachstumsverhalten spontaner Mamma-Karzinome bei C3H-Inzuchtmäusen. (in German), Archive der Geschwulstforschung, 45, 782-794.
23. MAGIN, R. L., BACIC, G., NIESMAN, M. R., ALAMEDA, J. C., WRIGHT, S. M. and SWARTZ, H. M., 1991. Dexran magnetite as a liver contrast agent. Magnetic Resonance in Medicine, 20, 1-16.
24. MARCHAL, G., VAN HECKE, P., DEMAEREL, P., DECROP, E., KENNIS, C., BAERT, A. L. and VAN DER SCHUEREN, E., 1988. Detection of liver metastases with superparamagnetic iron oxide in 15 patients; results of MR imaging at 1.5 T. American Journal of Radiology, 152, 771-775.
25. MITROVICS, T., SAMPAOLO, S., JORDAN, A., WUST, P., CERVOS-NAVARRO, J. and FELIX, R., 1994. Effect of magnetic fluid hyperthermia on neoplastic tissue: a histopathologic study. Clinical Neuropathology, 13, 258.
26. MITSUMORI, M., HIRAOKA, M., SHIBATA, T., OKUNO, Y., MASUNAGA, S., KOISHI, K., OKAJFMA, K., NAGATA, Y., NISHIMURA, Y., ABE, M., OHURA, K., HASEGAWA, M., NAGAE, H. and EBISAWA, Y., 1994. Development of intra-arterial hyperthermia using a dextran-magnetite complex. International Journal of Hyperthermia, 10, 785-793.
27. MORIMOTO, Y., ASHI, K. S., OKUMURA, M. and KATO, Y., 1980. Biomedical applications of magnetic fluids. I. Magnetic guidance of ferro-colloid-entrapped albumin microsphere for site specific drug delivery in vivo. Journal of Pharmacodynamics, 3, 264-267.
28. MORIMOTO, Y., OKUMURA, M., SUGIBAYASHI, K. and KATO, Y., 1981. Biomedical applications of magnetic fluids. II. Preparation and magnetic guidance of magnetic albumin microsphere for site specific drug delivery in vivo. Journal of Pharmacodynamics, 4, 624-631.
29. POULIQUEN, D., LE JEUNE, J. J., PERDRISOT, R., ERMIAS, A. and JALLET, P., 1991, Iron oxide nanoparticles for use as an MRI contrast agent; pharmacokinetics and metabolism, Magnetic Resonance Imaging, 9, 275-283.
30. 2 relaxation effects. Magnetic Resonance Imaging, 11, 219-228.
31. RENSHAW, P. F., OWEN, C. S., EVANS, A. E. and LEIGH, J. S., 1986. Immunospecific NMR contrast agents. Magnetic Resonance Imaging, 4, 351-357.
32. RUMMENY, E., WEISSLEDER, R., STARK, D. D., ELIZONDO, G., FERRUCCI, J. T., 1988. Kernspintomographie fokaler Leber- und Milzläsionen. Radiologe, 28, 380-386.
33. SAINI, S., STARK, D. D., HAHN, P. F., WITTENBERG, J., BRADY, T. J. and FERRUCCI, J. T., 1987a. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology, 162, 211-216.
34. SAINI, S., STARK, D. D., HAHN, P. F., BOUSQUET, J.-C., INTROCASSO, J., WITTENBERG, J., BRADY, T. J. and FERRUCCI, J. T., 1987b. Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma. Radiology, 162, 217-222.
35. STEEL, G. G., 1977. Growth rate of tumours. In: Growth Kinetics of Tumors: Cell Population Kinetics in Relation to the Growth and Treatment of Cancer (Oxford: Clarendon Press), pp. 5-55.
36. TAZAWA, 1989. European Patent Application EP 0 444 194 A1.
37. VALBERG, P. A., 1984. Magnetometry of ingested particles in pulmonary macrophages. Science, 224, 513-516.
38. WAGNER, S., PFEFFERER, D., TAUPITZ, M., KRESSE, M., LAWACZECK, R., HAMM, B. and WOLF, H.-J., 1992. Intravenous MR-lymphography with ultrasmall iron oxide particles: In vivo and ex vivo examinations in rats. Proceedings of Society of Magnetic Resonance in Medicine, Book of Abstracts, p. 570.
39. WIDDER, K. J., SENYEI, A. E. and RANNEY, D. F., 1982. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumour agents. Advances in Pharmacology and Chemotherapy, 16, 213-271.
40. YEH, T., ZHANG, W., ILDSTAD, S. T. and Ho, C., 1993. Intracellular labeling of T-cells with superparamagnetic contrast agents. Magnetic Resonance in Medicine, 30, 617-625.